GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » Notes Receivable

ADGM (Adagio Medical Holdings) Notes Receivable : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings Notes Receivable?

Adagio Medical Holdings's Notes Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.


Adagio Medical Holdings Notes Receivable Historical Data

The historical data trend for Adagio Medical Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings Notes Receivable Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
Notes Receivable
- - -

Adagio Medical Holdings Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Adagio Medical Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Adagio Medical Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Adagio Medical Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.